The effect of ondansetron, a 5-Ht3 receptor antagonist, on fatigue severity and functional impairment in CFS-patients.
Completed
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. CDC-diagnosed CFS-patients;
Exclusion Criteria
1. Pregancy;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Fatigue severity: measured with Checklist Individual Strenght;<br><br />2. Functional impairment: measured with Sickness Impact Profile;<br><br />. CDC-symptoms.
- Secondary Outcome Measures
Name Time Method Fysical activity level: measured with actometer.<br>